Modulation of invasive properties of human glioblastoma cells stably expressing amino-terminal fragment of urokinase-type plasminogen activator

Sanjeeva Mohanam, Nirmala Chandrasekar, Niranjan Yanamandra, Siddique Khawar, Faiz Mirza, Dzung H. Dinh, William C. Olivero, Jasti S. Rao

Research output: Contribution to journalArticle

Abstract

The binding of urokinase-type plasminogen activator (uPA) to its receptor (uPAR) on the surface of tumor cells is involved in the activation of proteolytic cascades responsible for the invasiveness of those cells. The diffuse, extensive infiltration of glioblastomas into the surrounding normal brain tissue is believed to rely on modifications of the proteolysis of extracellular matrix components; blocking the interaction between uPA and uPAR might be a suitable approach for inhibiting glioma tumorigenesis. We assessed how expression of an amino-terminal fragment (ATF) of uPA that contains binding site to uPAR affects the invasiveness of SNB19 human glioblastoma cells. SNB19 cells were transfected with an expression plasmid (pcDNA3-ATF) containing a cDNA sequence of ATF-uPA. The resulting ATF-uPA-expressing clones showed markedly less cell adhesion, spreading, and clonogenicity than did control cells. Endogenous ATF expression also significantly decreased the invasive capacity of transfected glioblastoma cells in Matrigel and spheroid-rat brain cell aggregate models. ATF-uPA transfectants were also markedly less invasive than parental SNB19 cells after injection into the brains of nude mice, suggesting that competitive inhibition of the uPA-uPAR interaction on SNB19 cells by means of transfection with ATF cDNA could be a useful therapeutic strategy for inhibiting tumor progression.

Original languageEnglish (US)
Pages (from-to)7824-7830
Number of pages7
JournalOncogene
Volume21
Issue number51
DOIs
StatePublished - Nov 7 2002

Fingerprint

Urokinase-Type Plasminogen Activator
Glioblastoma
Brain
Complementary DNA
Nude Mice
Cell Adhesion
Glioma
Proteolysis
Extracellular Matrix
Transfection
Neoplasms
Carcinogenesis
Plasmids
Clone Cells
Binding Sites
Injections

Keywords

  • ATF
  • Glioblastoma
  • Invasiveness
  • uPA

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Mohanam, S., Chandrasekar, N., Yanamandra, N., Khawar, S., Mirza, F., Dinh, D. H., ... Rao, J. S. (2002). Modulation of invasive properties of human glioblastoma cells stably expressing amino-terminal fragment of urokinase-type plasminogen activator. Oncogene, 21(51), 7824-7830. https://doi.org/10.1038/sj.onc.1205893

Modulation of invasive properties of human glioblastoma cells stably expressing amino-terminal fragment of urokinase-type plasminogen activator. / Mohanam, Sanjeeva; Chandrasekar, Nirmala; Yanamandra, Niranjan; Khawar, Siddique; Mirza, Faiz; Dinh, Dzung H.; Olivero, William C.; Rao, Jasti S.

In: Oncogene, Vol. 21, No. 51, 07.11.2002, p. 7824-7830.

Research output: Contribution to journalArticle

Mohanam, S, Chandrasekar, N, Yanamandra, N, Khawar, S, Mirza, F, Dinh, DH, Olivero, WC & Rao, JS 2002, 'Modulation of invasive properties of human glioblastoma cells stably expressing amino-terminal fragment of urokinase-type plasminogen activator', Oncogene, vol. 21, no. 51, pp. 7824-7830. https://doi.org/10.1038/sj.onc.1205893
Mohanam, Sanjeeva ; Chandrasekar, Nirmala ; Yanamandra, Niranjan ; Khawar, Siddique ; Mirza, Faiz ; Dinh, Dzung H. ; Olivero, William C. ; Rao, Jasti S. / Modulation of invasive properties of human glioblastoma cells stably expressing amino-terminal fragment of urokinase-type plasminogen activator. In: Oncogene. 2002 ; Vol. 21, No. 51. pp. 7824-7830.
@article{7b04f76611ff40d9bbb0b60d9e6df70e,
title = "Modulation of invasive properties of human glioblastoma cells stably expressing amino-terminal fragment of urokinase-type plasminogen activator",
abstract = "The binding of urokinase-type plasminogen activator (uPA) to its receptor (uPAR) on the surface of tumor cells is involved in the activation of proteolytic cascades responsible for the invasiveness of those cells. The diffuse, extensive infiltration of glioblastomas into the surrounding normal brain tissue is believed to rely on modifications of the proteolysis of extracellular matrix components; blocking the interaction between uPA and uPAR might be a suitable approach for inhibiting glioma tumorigenesis. We assessed how expression of an amino-terminal fragment (ATF) of uPA that contains binding site to uPAR affects the invasiveness of SNB19 human glioblastoma cells. SNB19 cells were transfected with an expression plasmid (pcDNA3-ATF) containing a cDNA sequence of ATF-uPA. The resulting ATF-uPA-expressing clones showed markedly less cell adhesion, spreading, and clonogenicity than did control cells. Endogenous ATF expression also significantly decreased the invasive capacity of transfected glioblastoma cells in Matrigel and spheroid-rat brain cell aggregate models. ATF-uPA transfectants were also markedly less invasive than parental SNB19 cells after injection into the brains of nude mice, suggesting that competitive inhibition of the uPA-uPAR interaction on SNB19 cells by means of transfection with ATF cDNA could be a useful therapeutic strategy for inhibiting tumor progression.",
keywords = "ATF, Glioblastoma, Invasiveness, uPA",
author = "Sanjeeva Mohanam and Nirmala Chandrasekar and Niranjan Yanamandra and Siddique Khawar and Faiz Mirza and Dinh, {Dzung H.} and Olivero, {William C.} and Rao, {Jasti S.}",
year = "2002",
month = "11",
day = "7",
doi = "10.1038/sj.onc.1205893",
language = "English (US)",
volume = "21",
pages = "7824--7830",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "51",

}

TY - JOUR

T1 - Modulation of invasive properties of human glioblastoma cells stably expressing amino-terminal fragment of urokinase-type plasminogen activator

AU - Mohanam, Sanjeeva

AU - Chandrasekar, Nirmala

AU - Yanamandra, Niranjan

AU - Khawar, Siddique

AU - Mirza, Faiz

AU - Dinh, Dzung H.

AU - Olivero, William C.

AU - Rao, Jasti S.

PY - 2002/11/7

Y1 - 2002/11/7

N2 - The binding of urokinase-type plasminogen activator (uPA) to its receptor (uPAR) on the surface of tumor cells is involved in the activation of proteolytic cascades responsible for the invasiveness of those cells. The diffuse, extensive infiltration of glioblastomas into the surrounding normal brain tissue is believed to rely on modifications of the proteolysis of extracellular matrix components; blocking the interaction between uPA and uPAR might be a suitable approach for inhibiting glioma tumorigenesis. We assessed how expression of an amino-terminal fragment (ATF) of uPA that contains binding site to uPAR affects the invasiveness of SNB19 human glioblastoma cells. SNB19 cells were transfected with an expression plasmid (pcDNA3-ATF) containing a cDNA sequence of ATF-uPA. The resulting ATF-uPA-expressing clones showed markedly less cell adhesion, spreading, and clonogenicity than did control cells. Endogenous ATF expression also significantly decreased the invasive capacity of transfected glioblastoma cells in Matrigel and spheroid-rat brain cell aggregate models. ATF-uPA transfectants were also markedly less invasive than parental SNB19 cells after injection into the brains of nude mice, suggesting that competitive inhibition of the uPA-uPAR interaction on SNB19 cells by means of transfection with ATF cDNA could be a useful therapeutic strategy for inhibiting tumor progression.

AB - The binding of urokinase-type plasminogen activator (uPA) to its receptor (uPAR) on the surface of tumor cells is involved in the activation of proteolytic cascades responsible for the invasiveness of those cells. The diffuse, extensive infiltration of glioblastomas into the surrounding normal brain tissue is believed to rely on modifications of the proteolysis of extracellular matrix components; blocking the interaction between uPA and uPAR might be a suitable approach for inhibiting glioma tumorigenesis. We assessed how expression of an amino-terminal fragment (ATF) of uPA that contains binding site to uPAR affects the invasiveness of SNB19 human glioblastoma cells. SNB19 cells were transfected with an expression plasmid (pcDNA3-ATF) containing a cDNA sequence of ATF-uPA. The resulting ATF-uPA-expressing clones showed markedly less cell adhesion, spreading, and clonogenicity than did control cells. Endogenous ATF expression also significantly decreased the invasive capacity of transfected glioblastoma cells in Matrigel and spheroid-rat brain cell aggregate models. ATF-uPA transfectants were also markedly less invasive than parental SNB19 cells after injection into the brains of nude mice, suggesting that competitive inhibition of the uPA-uPAR interaction on SNB19 cells by means of transfection with ATF cDNA could be a useful therapeutic strategy for inhibiting tumor progression.

KW - ATF

KW - Glioblastoma

KW - Invasiveness

KW - uPA

UR - http://www.scopus.com/inward/record.url?scp=0037038668&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037038668&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1205893

DO - 10.1038/sj.onc.1205893

M3 - Article

VL - 21

SP - 7824

EP - 7830

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 51

ER -